{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:08:22Z","timestamp":1790842102379,"version":"4.1.0"},"reference-count":25,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":237,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"NIH\/NCI","award":["R01 CA124763"],"award-info":[{"award-number":["R01 CA124763"]}]},{"DOI":"10.13039\/501100001332","name":"CSIR","doi-asserted-by":"crossref","award":["21(0895)\/12EMR-II to P.S.D"],"award-info":[{"award-number":["21(0895)\/12EMR-II to P.S.D"]}],"id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2015,8,1]]},"DOI":"10.1002\/ijc.29414","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T13:57:54Z","timestamp":1419861474000},"page":"744-749","source":"Crossref","is-referenced-by-count":40,"title":["Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia"],"prefix":"10.1002","volume":"137","author":[{"given":"Chandrani","family":"Sarkar","sequence":"first","affiliation":[{"name":"Department of Pathology; Ohio State University; Columbus OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debanjan","family":"Chakroborty","sequence":"additional","affiliation":[{"name":"Department of Pathology; Ohio State University; Columbus OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha Sarathi","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Chittaranjan National Cancer Institute; Kolkata 700026 India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit","family":"Basu","sequence":"additional","affiliation":[{"name":"Department of Pathology; Ohio State University; Columbus OH"},{"name":"Division of Medical Oncology, Department of Internal Medicine; Ohio State University; Columbus OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,7]]},"reference":[{"key":"10.1002\/ijc.29414-BIB0001|ijc29414-cit-0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1002\/ijc.29414-BIB0002|ijc29414-cit-0002","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/j.1538-7836.2005.01361.x","article-title":"Angiogenesis: update 2005","volume":"3","author":"Dvorak","year":"2005","journal-title":"J Thromb Haemos"},{"key":"10.1002\/ijc.29414-BIB0003|ijc29414-cit-0003","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1101-1194","article-title":"Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth","volume":"7","author":"Lyden","year":"2001","journal-title":"Nat Med"},{"key":"10.1002\/ijc.29414-BIB0004|ijc29414-cit-0004","first-page":"1324","article-title":"Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy","volume":"9","author":"Sloan","year":"2008","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1002\/ijc.29414-BIB0005|ijc29414-cit-0005","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4161\/mabs.2.2.11360","article-title":"The VEGF family in cancer and antibody-based strategies for their inhibition","volume":"2","author":"Sullivan","year":"2010","journal-title":"MAbs"},{"key":"10.1002\/ijc.29414-BIB0006|ijc29414-cit-0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"10.1002\/ijc.29414-BIB0007|ijc29414-cit-0007","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2144\/03345dd01","article-title":"Antiangiogenic tumor therapy","volume":"34","author":"Davis","year":"2003","journal-title":"Biotechniques"},{"key":"10.1002\/ijc.29414-BIB0008|ijc29414-cit-0008","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","article-title":"Adverse effects of anticancer agents that target the VEGF pathway","volume":"6","author":"Chen","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1002\/ijc.29414-BIB0009|ijc29414-cit-0009","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1345\/aph.1L426","article-title":"Intricacies of bevacizumab-induced toxicities and their management","volume":"43","author":"Gressett","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1002\/ijc.29414-BIB0010|ijc29414-cit-0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/87895","article-title":"The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor\/vascular endothelial growth factor","volume":"7","author":"Basu","year":"2001","journal-title":"Nat Med"},{"key":"10.1002\/ijc.29414-BIB0011|ijc29414-cit-0011","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1158\/1078-0432.CCR-04-0059","article-title":"Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis","volume":"10","author":"Chakroborty","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.29414-BIB0012|ijc29414-cit-0012","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1158\/1078-0432.CCR-07-1778","article-title":"Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models","volume":"14","author":"Sarkar","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.29414-BIB0013|ijc29414-cit-0013","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1172\/JCI33125","article-title":"Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization","volume":"118","author":"Chakroborty","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1002\/ijc.29414-BIB0014|ijc29414-cit-0014","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1158\/1078-0432.CCR-10-2441","article-title":"Dopamine blocks stress-mediated ovarian carcinoma growth","volume":"17","author":"Moreno-Smith","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.29414-BIB0015|ijc29414-cit-0015","first-page":"5209","article-title":"Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors","volume":"59","author":"Prewett","year":"1999","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.29414-BIB0016|ijc29414-cit-0016","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00000542-200002000-00013","article-title":"Pharmacokinetics of dopamine in healthy male subjects","volume":"92","author":"MacGregor","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1002\/ijc.29414-BIB0017|ijc29414-cit-0017","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cmet.2014.05.022","article-title":"Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal","volume":"20","author":"Sounni","year":"2014","journal-title":"Cell Metab"},{"key":"10.1002\/ijc.29414-BIB0018|ijc29414-cit-0018","doi-asserted-by":"crossref","first-page":"20730","DOI":"10.1073\/pnas.1108696108","article-title":"Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells","volume":"108","author":"Chakroborty","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/ijc.29414-BIB0019|ijc29414-cit-0019","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/HYPERTENSIONAHA.109.129973","article-title":"Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression","volume":"54","author":"Facemire","year":"2009","journal-title":"Hypertension"},{"key":"10.1002\/ijc.29414-BIB0020|ijc29414-cit-0020","doi-asserted-by":"crossref","first-page":"e93920","DOI":"10.1371\/journal.pone.0093920","article-title":"Arsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivo","volume":"9","author":"Ezeh","year":"2014","journal-title":"PLoS One"},{"key":"10.1002\/ijc.29414-BIB0021|ijc29414-cit-0021","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11912-012-0242-z","article-title":"VEGF inhibition, hypertension, and renal toxicity","volume":"14","author":"Hayman","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1002\/ijc.29414-BIB0022|ijc29414-cit-0022","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2214\/AJR.11.7432","article-title":"Decade of molecular targeted therapy: abdominal manifestations of drug toxicities-what radiologists should know","volume":"199","author":"Howard","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1002\/ijc.29414-BIB0023|ijc29414-cit-0023","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1188\/13.CJON.425-433","article-title":"Managing toxicities associated with antiangiogenic biologic agents in combination with chemotherapy for metastatic colorectal cancer","volume":"17","author":"Grenon","year":"2013","journal-title":"Clin J Oncol Nurs"},{"key":"10.1002\/ijc.29414-BIB0024|ijc29414-cit-0024","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00000421-198610000-00009","article-title":"Toxicity studies of adjuvant intravenous versus intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer","volume":"9","author":"Gianola","year":"1986","journal-title":"Am J Clin Oncol"},{"key":"10.1002\/ijc.29414-BIB0025|ijc29414-cit-0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejphar.2005.08.053","article-title":"Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment","volume":"522","author":"Djazayeri","year":"2005","journal-title":"Eur J Pharmacol"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.29414","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.29414","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ijc.29414\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:16:05Z","timestamp":1625141765000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.29414"}},"subtitle":["DA a Safe Antiangiogenic Drug"],"short-title":[],"issued":{"date-parts":[[2015,1,7]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.29414","archive":["Portico"],"relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,7]]}}}